OMEROS CORP Revenues
OMEROS CORP (OMER) reported Revenues of $21.78 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2019-05-09
- OMEROS CORP revenues for the quarter ending 2019-03-31 was $21.78M, a 1271.47% increase year-over-year.
- OMEROS CORP revenues for the quarter ending 2018-12-31 was $22.02M, a 60.01% increase year-over-year.
- OMEROS CORP revenues for the quarter ending 2018-09-30 was $4.61M, a 78.72% decline year-over-year.
- OMEROS CORP revenues for the quarter ending 2018-06-30 was $1.66M, a 90.35% decline year-over-year.
- OMEROS CORP revenues for fiscal 2018 was $29.87M, a 53.93% decline from fiscal 2017.
- OMEROS CORP revenues for fiscal 2017 was $64.83M, a 55.77% increase from fiscal 2016.
- OMEROS CORP revenues for fiscal 2016 was $41.62M, a 208.07% increase from fiscal 2015.
- OMEROS CORP revenues for fiscal 2015 was $13.51M, a 2406.31% increase from fiscal 2014.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month | Revenues 204 month | Revenues 207 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | $21.78M 10-Q · filed 2019-05-09 | $43.80M derived: sum of 2 quarters · filed 2019-05-09 | $48.40M derived: sum of 3 quarters · filed 2019-05-09 | $50.06M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-12-31 | $22.02M 10-K · filed 2019-03-01 | $26.63M derived: sum of 2 quarters · filed 2019-03-01 | $28.28M derived: sum of 3 quarters · filed 2019-03-01 | $29.87M 10-K · filed 2019-03-01 | ||
| 2018-09-30 | $4.61M 10-K · filed 2019-03-01 | $6.26M derived: sum of 2 quarters · filed 2019-03-01 | $7.85M 10-Q · filed 2018-11-08 | $21.61M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-06-30 | $1.66M 10-K · filed 2019-03-01 | $3.24M derived: sum of 2 quarters · filed 2019-05-09 | $17.00M derived: sum of 3 quarters · filed 2019-05-09 | $38.66M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-03-31 | $1.59M 10-Q · filed 2019-05-09 | $15.35M derived: sum of 2 quarters · filed 2019-05-09 | $37.01M derived: sum of 3 quarters · filed 2019-05-09 | $54.16M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $13.76M 10-K · filed 2019-03-01 | $35.42M derived: sum of 2 quarters · filed 2019-03-01 | $52.57M derived: sum of 3 quarters · filed 2019-03-01 | $64.83M 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $21.66M 10-K · filed 2019-03-01 | $38.81M derived: sum of 2 quarters · filed 2019-03-01 | $51.07M 10-Q · filed 2018-11-08 | $63.97M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $17.15M 10-K · filed 2019-03-01 | $29.41M 10-Q · filed 2017-08-08 | $42.31M derived: sum of 3 quarters · filed 2019-03-01 | $53.60M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $12.26M 10-K · filed 2019-03-01 | $25.16M derived: sum of 2 quarters · filed 2019-03-01 | $36.45M derived: sum of 3 quarters · filed 2019-03-01 | $46.45M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | $12.90M 10-K · filed 2018-03-01 | $24.19M derived: sum of 2 quarters · filed 2018-03-01 | $34.20M derived: sum of 3 quarters · filed 2018-03-01 | $41.62M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $11.29M 10-K · filed 2018-03-01 | $21.29M derived: sum of 2 quarters · filed 2018-03-01 | $28.71M 10-Q · filed 2017-11-09 | $35.39M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $10.00M 10-K · filed 2018-03-01 | $17.42M 10-Q · filed 2017-08-08 | $24.10M derived: sum of 3 quarters · filed 2018-03-01 | $27.36M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $7.42M 10-K · filed 2018-03-01 | $14.09M derived: sum of 2 quarters · filed 2018-03-01 | $17.35M derived: sum of 3 quarters · filed 2018-03-01 | $20.54M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $6.67M 10-K · filed 2017-03-16 | $9.93M derived: sum of 2 quarters · filed 2017-03-16 | $13.12M derived: sum of 3 quarters · filed 2017-03-16 | $13.51M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $3.26M 10-K · filed 2017-03-16 | $6.45M derived: sum of 2 quarters · filed 2017-03-16 | $6.83M 10-Q · filed 2016-11-09 | $7.01M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $3.19M 10-K · filed 2017-03-16 | $3.58M 10-Q · filed 2016-08-09 | $3.75M derived: sum of 3 quarters · filed 2017-03-16 | $3.97M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | $388.00K 10-K · filed 2017-03-16 | $568.00K derived: sum of 2 quarters · filed 2017-03-16 | $782.00K derived: sum of 3 quarters · filed 2017-03-16 | $827.00K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | $180.00K 10-K · filed 2016-03-15 | $394.00K derived: sum of 2 quarters · filed 2016-03-15 | $439.00K derived: sum of 3 quarters · filed 2016-03-15 | $539.00K 10-K · filed 2017-03-16 | ||
| 2014-09-30 | $214.00K 10-K · filed 2016-03-15 | $259.00K derived: sum of 2 quarters · filed 2016-03-15 | $359.00K 10-Q · filed 2015-11-09 | $528.00K derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $45.00K 10-K · filed 2016-03-15 | $145.00K 10-Q · filed 2015-08-10 | $314.00K derived: sum of 3 quarters · filed 2016-03-15 | $510.00K derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $100.00K 10-K · filed 2016-03-15 | $269.00K derived: sum of 2 quarters · filed 2016-03-15 | $465.00K derived: sum of 3 quarters · filed 2016-03-15 | $605.00K derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2013-12-31 | $169.00K 10-K · filed 2015-03-16 | $365.00K derived: sum of 2 quarters · filed 2015-03-16 | $505.00K derived: sum of 3 quarters · filed 2015-03-16 | $1.60M 10-K · filed 2016-03-15 | ||
| 2013-09-30 | $196.00K 10-K · filed 2015-03-16 | $336.00K derived: sum of 2 quarters · filed 2015-03-16 | $1.43M 10-Q · filed 2014-11-10 | $3.01M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $140.00K 10-K · filed 2015-03-16 | $1.24M 10-Q · filed 2014-08-11 | $2.82M derived: sum of 3 quarters · filed 2015-03-16 | $4.24M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $1.09M 10-K · filed 2015-03-16 | $2.68M derived: sum of 2 quarters · filed 2015-03-16 | $4.09M derived: sum of 3 quarters · filed 2015-03-16 | $5.62M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | $1.58M 10-K · filed 2014-03-13 | $3.00M derived: sum of 2 quarters · filed 2014-03-13 | $4.53M derived: sum of 3 quarters · filed 2014-03-13 | $6.02M 10-K · filed 2015-03-16 | ||
| 2012-09-30 | $1.42M 10-K · filed 2014-03-13 | $2.94M derived: sum of 2 quarters · filed 2014-03-13 | $4.44M 10-Q · filed 2013-11-07 | $5.58M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-06-30 | $1.53M 10-K · filed 2014-03-13 | $3.02M 10-Q · filed 2013-08-09 | $4.17M derived: sum of 3 quarters · filed 2014-03-13 | $5.15M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-03-31 | $1.50M 10-K · filed 2014-03-13 | $2.64M derived: sum of 2 quarters · filed 2014-03-13 | $3.63M derived: sum of 3 quarters · filed 2014-03-13 | $4.78M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2011-12-31 | $1.14M 10-K · filed 2013-03-18 | $2.13M derived: sum of 2 quarters · filed 2013-03-18 | $3.29M derived: sum of 3 quarters · filed 2013-03-18 | $4.52M 10-K · filed 2014-03-13 | ||
| 2011-09-30 | $987.00K 10-K · filed 2013-03-18 | $2.14M derived: sum of 2 quarters · filed 2013-03-18 | $3.38M 10-Q · filed 2012-11-09 | $4.36M derived: sum of 4 quarters · filed 2013-03-18 | $10.32M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $1.16M 10-K · filed 2013-03-18 | $2.39M 10-Q · filed 2012-08-07 | $3.37M derived: sum of 3 quarters · filed 2013-03-18 | $3.62M derived: sum of 4 quarters · filed 2013-03-18 | $9.34M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $1.24M 10-K · filed 2013-03-18 | $2.21M derived: sum of 2 quarters · filed 2013-03-18 | $2.47M derived: sum of 3 quarters · filed 2013-03-18 | $2.97M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $976.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.23M derived: sum of 2 quarters · filed 2013-03-18 | $1.73M derived: sum of 3 quarters · filed 2013-03-18 | $2.10M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $254.00K 10-Q · filed 2011-11-08 | $751.00K derived: sum of 2 quarters · filed 2011-11-08 | $1.13M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $497.00K 10-Q · filed 2011-08-09 | $875.00K 10-Q · filed 2011-08-09 | ||||
| 2009-12-31 | $1.44M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |